{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:11:44Z","timestamp":1785424304056,"version":"3.56.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Sleep"],"abstract":"<jats:p>Obstructive sleep apnea (OSA) is a common disorder. Its prevalence is increasing worldwide, partially due to increasing rates of obesity, and OSA has a well-documented impact on physical health (increased risk of cardiovascular and metabolic disorders) and mental health, as well as major socioeconomic implications. Although continuous positive airway pressure treatment (CPAP) remains the primary therapeutic intervention for moderate to severe OSA, other treatment strategies such as weight loss, positional therapy, mandibular advancement devices (MAD), surgical treatment, myofunctional therapy of upper airways (UA) muscles and hypoglossal nerve stimulation are increasingly used. Recently, several trials have demonstrated the clinical potential for various pharmacological treatments that aim to improve UA muscle dysfunction, loop gain, or excessive daytime sleepiness. In line with the highly heterogeneous clinical picture of OSA, recent identification of different clinical phenotypes has been documented. Comorbidities, incident cardiovascular risk, and response to CPAP may vary significantly among phenotypes. With this in mind, the purpose of this review is to summarize the data on OSA phenotypes that may respond to pharmacological approaches.<\/jats:p>","DOI":"10.3389\/frsle.2023.1261276","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:51:55Z","timestamp":1693583515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Obstructive sleep apnea phenotypes eligible for pharmacological treatment"],"prefix":"10.3389","volume":"2","author":[{"given":"Marie","family":"Bruyneel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"B1","volume-title":"The International Classification of Sleep Disorders, 3rd Edn","year":"2014"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e005899","DOI":"10.1161\/JAHA.116.005899","article-title":"Phenotyping of sleep-disordered breathing in patients with chronic heart failure with reduced ejection fraction-the SchlaHF registry","volume":"6","author":"Arzt","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.5664\/jcsm.4556","article-title":"Quality measures for the care of adult patients with obstructive sleep apnea","volume":"11","author":"Aurora","year":"2015","journal-title":"J. Clin. Sleep Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1164\/ajrccm.151.2.7842205","article-title":"Triazolam in patients with obstructive sleep apnea","volume":"151","author":"Berry","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/ijerph17062058","article-title":"Qualitative phenotyping of obstructive sleep apnea and its clinical usefulness for the sleep specialist","volume":"17","author":"Bosi","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11325-021-02501-1","article-title":"The predictive value of drug-induced sleep endoscopy for treatment success with a mandibular advancement device or positional therapy for patients with obstructive sleep apnea","volume":"26","author":"Bosschieter","year":"2022","journal-title":"Sleep Breath"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1701344","DOI":"10.1183\/13993003.01344-2017","article-title":"Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem","volume":"50","author":"Carberry","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsx184","article-title":"Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: effects of dronabinol in obstructive sleep apnea","author":"Carley","year":"2018","journal-title":"Sleep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.3390\/ijerph18147291","article-title":"The role of myofunctional therapy in treating sleep-disordered breathing: a state-of-the-art review","volume":"8","author":"Carrasco-Llatas","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101492","article-title":"Effects of hypnotics on obstructive sleep apnea endotypes and severity: novel insights into pathophysiology and treatment","author":"Carter","year":"2021","journal-title":"Sleep Med. Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1183\/13993003.01509-2015","article-title":"Modafinil\/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis","volume":"47","author":"Chapman","year":"2016","journal-title":"Eur. Respir. J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1164\/rccm.201907-1284OC","article-title":"Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. A randomized trial","volume":"201","author":"Dauvilliers","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1513\/AnnalsATS.202001-064OC","article-title":"A novel model to estimate key obstructive sleep apnea endotypes from standard polysomnography and clinical data and their contribution to obstructive sleep apnea severity","volume":"18","author":"Dutta","year":"2021","journal-title":"Ann. Am. Thorac. Soc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.smrv.2016.12.003","article-title":"Phenotypic approaches to obstructive sleep apnoea - New pathways for targeted therapy","volume":"37","author":"Eckert","year":"2018","journal-title":"Sleep Med. Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1164\/rccm.201404-0718OC","article-title":"Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea","volume":"190","author":"Edwards","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","article-title":"Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea","volume":"590","author":"Edwards","year":"2012","journal-title":"J. Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1183\/13993003.congress-2019.PA4168","article-title":"Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis","volume":"46","author":"Gaisl","year":"2019","journal-title":"Sleep Med. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s11739-022-02983-1","article-title":"Treatment options in obstructive sleep apnea","volume":"17","author":"Gambino","year":"2022","journal-title":"Int. Emerg. Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea: a review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1164\/rccm.202109-2043OC","article-title":"A randomized controlled clinical trial exploring safety and tolerability of sulthiame in sleep apnea","volume":"205","author":"Hedner","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S2213-2600(15)00043-0","article-title":"Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study","volume":"3","author":"Heinzer","year":"2015","journal-title":"Lancet Respir. Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.smrv.2013.01.003","article-title":"Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review","volume":"18","author":"Kendzerska","year":"2014","journal-title":"Sleep Med. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.clinthera.2016.02.004","article-title":"Effects of modafinil and armodafinil in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials","volume":"38","author":"Kuan","year":"2016","journal-title":"Clin. Ther."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1183\/1025448x.00024809","article-title":"Diabetes and metabolic aspects of OSA","author":"Lam","year":"2010","journal-title":"Sleep Apnea"},{"key":"B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jsmc.2019.05.005","article-title":"Precision medicine for obstructive sleep apnea","volume":"14","author":"Light","year":"2019","journal-title":"Sleep Med. Clin"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1113\/JP281912","article-title":"The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial","volume":"599","author":"Lim","year":"2021","journal-title":"J. Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0140-6736(05)71141-7","article-title":"Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study","volume":"365","author":"Marin","year":"2005","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/archinternmed.2009.138","article-title":"Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study","volume":"169","author":"Mehra","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1513\/AnnalsATS.202205-419OC","article-title":"Effect of pimavanserin on the respiratory arousal threshold from sleep: a randomized trial","volume":"19","author":"Messineo","year":"2022","journal-title":"Ann. Am. Thorac. Soc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1113\/JP276206","article-title":"Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnoea","volume":"596","author":"Messineo","year":"2018","journal-title":"J. Physiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.283","article-title":"Assessment of muscular weakness in severe sleep apnea patients: a prospective study","author":"O'Connor-Reina","year":"2023","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.5665\/sleep.4750","article-title":"An integrative model of physiological traits can be used to predict obstructive sleep apnea and response to non positive airway pressure therapy","volume":"38","author":"Owens","year":"2015","journal-title":"Sleep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.chest.2020.09.281","article-title":"Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial","volume":"159","author":"P\u00e9pin","year":"2021","journal-title":"Chest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.chest.2021.08.080","article-title":"Reboxetine plus oxybutynin for OSA treatment: a 1-week, randomized, placebo-controlled, double-blind crossover trial","volume":"161","author":"Perger","year":"2022","journal-title":"Chest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e13066","DOI":"10.1111\/jsr.13066","article-title":"On the rise and fall of the apnea-hypopnea index: a historical review and critical appraisal","volume":"29","author":"Pevernagie","year":"2020","journal-title":"J. Sleep Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/M22-3473","article-title":"Comparative efficacy and safety of wakefulness-promoting agents for excessive daytime sleepiness in patients with obstructive sleep apnea: a systematic review and network meta-analysis","volume":"176","author":"Pitre","year":"2023","journal-title":"Ann. Intern. Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/lary.28663","article-title":"The value of oxygen desaturation index for diagnosing obstructive sleep apnea: a systematic review","volume":"131","author":"Rashid","year":"2021","journal-title":"Laryngoscope"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.chest.2020.06.078","article-title":"Acetazolamide for OSA and central sleep apnea: a comprehensive systematic review and meta-analysis","volume":"158","author":"Schmickl","year":"2020","journal-title":"Chest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.rmed.2008.04.020","article-title":"Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea","volume":"102","author":"Tamura","year":"2008","journal-title":"Respir. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1164\/rccm.201808-1493OC","article-title":"The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial","volume":"199","author":"Taranto-Montemurro","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.sleep.2020.12.039","article-title":"Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials","volume":"79","author":"Wang","year":"2021","journal-title":"Sleep Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.chest.2019.09.002","article-title":"Phenotypic subtypes of OSA: a challenge and opportunity for precision medicine","volume":"157","author":"Zinchuk","year":"2020","journal-title":"Chest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.smrv.2016.10.002","article-title":"Phenotypes in obstructive sleep apnea: a definition, examples and evolution of approaches","volume":"35","author":"Zinchuk","year":"2017","journal-title":"Sleep Med. Rev"}],"container-title":["Frontiers in Sleep"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frsle.2023.1261276\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:51:58Z","timestamp":1693583518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frsle.2023.1261276\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":44,"alternative-id":["10.3389\/frsle.2023.1261276"],"URL":"https:\/\/doi.org\/10.3389\/frsle.2023.1261276","relation":{},"ISSN":["2813-2890"],"issn-type":[{"value":"2813-2890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"article-number":"1261276"}}